Live Breaking News & Updates on Cstone pharmaceuticals

Stay informed with the latest breaking news from Cstone pharmaceuticals on our comprehensive webpage. Get up-to-the-minute updates on local events, politics, business, entertainment, and more. Our dedicated team of journalists delivers timely and reliable news, ensuring you're always in the know. Discover firsthand accounts, expert analysis, and exclusive interviews, all in one convenient destination. Don't miss a beat — visit our webpage for real-time breaking news in Cstone pharmaceuticals and stay connected to the pulse of your community

Histone Deacetylase 6 Drug Pipeline Research Report 2024:

Dublin, April 12, 2024 (GLOBE NEWSWIRE) -- The

Dublin , Ireland , Regenacy-pharmaceuticalsricolinostat , Hillstream-biopharma , Karus-therapeutics , Chong-kun-dang-pharmaceuticals , Chong-kun-dang , Pipeline-development-activities , Celgene-corporation , Cstone-pharmaceuticals , Regenacy-pharmaceuticals , Shuttle-pharmaceuticals

Geopolitics threatens Chinese biotechs' hot out-licensing biz

Geopolitics threatens Chinese biotechs' hot out-licensing biz
fiercebiotech.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from fiercebiotech.com Daily Mail and Mail on Sunday newspapers.

China , United-states , Shanghai , Chinese , Daiichi-sankyo , Athena-countouriotis , Bristol-myers-squibb , Pfizer , Life-sciences , Merck-co , Cstone-pharmaceuticals , Avenzo-therapeutics

Ipsen Joins the ADC Chase, Licensing Phase 1-Ready Asset for Novel Cancer Target

Ipsen Joins the ADC Chase, Licensing Phase 1-Ready Asset for Novel Cancer Target
medcitynews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from medcitynews.com Daily Mail and Mail on Sunday newspapers.

France , Paris , France-general- , French , Sutro-biopharma , Lyell-immunopharma , Merrimack-pharmaceuticals , Cstone-pharmaceuticals , Boehringer-ingelheim ,

Adlai Nortye Announces Appointment of Dr. Archie Tse as the Head of Research & Development

SINGAPORE and NORTH BRUNSWICK, N.J. and HANGZHOU, China, March 29, 2024 -- Adlai Nortye Ltd. , a clinical-stage biotechnology company focused on the development of innovative cancer therapies,...

New-york , United-states , New-jersey , Memorial-sloan-kettering-cancer-center , Singapore , China , Canada , Hangzhou , Zhejiang , Amanda-kong , Adlai-nortye , Charles-zhou

Adlai Nortye Announces Appointment of Archie Tse as the Head of Research & Development

Adlai Nortye Ltd. announced the appointment of Dr. Archie Tse as Head of Research & Development, reporting to Mr. Carsten Lu, CEO and Chairman of Adlai Nortye, effective March 29th, 2024. Dr. Tse,...

New-york , United-states , Canada , Memorial-sloan-kettering-cancer-center , Adlai-nortye , Carsten-lu , Cstone-pharmaceuticals , Early-clinical-development , Head-of-research , Adlai-nortye-ltd , University-of-southern-california , Archie-tse-as-head-of-research-development

Adlai Nortye Announces Appointment of Dr. Archie Tse as the

Adlai Nortye Announces Appointment of Dr. Archie Tse as the
globenewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from globenewswire.com Daily Mail and Mail on Sunday newspapers.

China , Canada , Hangzhou , Zhejiang , Memorial-sloan-kettering-cancer-center , New-york , United-states , Singapore , New-jersey , Charles-zhou , Adlai-nortye , Amanda-kong

CStone Pharmaceuticals Reports 2023 Annual Results and Business Updates

SUZHOU, China, March 27, 2024 /PRNewswire/ -- CStone Pharmaceuticals ("CStone", HKEX: 2616), a leading biopharmaceutical company focused on research,

China , United-states , Thailand , United-kingdom , Singapore , London , City-of , Taiwan , Australia , Macau , Hong-kong , Suzhou

Blueprint drops lung cancer programs after seeing early data

Blueprint drops lung cancer programs after seeing early data
fiercebiotech.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from fiercebiotech.com Daily Mail and Mail on Sunday newspapers.

China , Kate-haviland , Astrazeneca-tagrisso , Cstone-pharmaceuticals , Blueprint-medicines , Healthcare-conference , Royalty-pharma ,

HongShan-backed OnCusp Therapeutics snags $100m Series A

OnCusp Therapeutics has raised $100 million in a Series A funding round co-led by Novo Holdings, OrbiMed, and F-Prime Capital.

Shanghai , China , Japan , Hongshan , Jiangxi , New-york , United-states , Japanese , Chong-xu , Eric-slosberg , Daiichi-sankyo , Diyong-xu

Sugemalimab Plus Chemo Receives Approval in China for Esophageal Squamous Cell Carcinoma

The National Medical Products Administration of China has approved sugemalimab paired with fluorouracil and platinum-based chemotherapy for use in the frontline treatment of patients with unresectable locally advanced, recurrent, or metastatic esophageal squamous cell carcinoma.

China , Tongji , Sichuan , Li-jin , Department-of-oncology-at-east-hospital , Cstone-pharmaceuticals , National-medical-products-administration-of-china , Tongji-university , National-medical-products-administration , East-hospital , National-medical-products-administration-of-china- , Sugemalimab-